Despite its advantages, PRA in toxicology faces several challenges. One significant issue is the data gaps for certain chemicals, especially new or less-studied substances. Additionally, the complexity of biological systems and the interactions between different chemicals can complicate the modeling process. There is also the challenge of effectively communicating probabilistic risk outcomes to stakeholders, including the general public, policymakers, and industry professionals, who may not be familiar with statistical concepts.
